Amy E. McKee, Director at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 8,600 shares at $6.32 ($54K) on 2024-06-24, disclosed to the SEC on 2024-06-25.
Open-market sale of $54k BCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.